Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus
-
Published:2023-02-22
Issue:1
Volume:18
Page:
-
ISSN:1750-1172
-
Container-title:Orphanet Journal of Rare Diseases
-
language:en
-
Short-container-title:Orphanet J Rare Dis
Author:
Ingen-Housz-Oro S.ORCID, Schmidt V., Ameri M. M., Abe R., Brassard A., Mostaghimi A., Paller A. S., Romano A., Didona B., Kaffenberger B. H., Ben Said B., Thong B. Y. H., Ramsay B., Brezinova E., Milpied B., Mortz C. G., Chu C. Y., Sotozono C., Gueudry J., Fortune D. G., Dridi S. M., Tartar D., Do-Pham G., Gabison E., Phillips E. J., Lewis F., Salavastru C., Horvath B., Dart J., Setterfield J., Newman J., Schulz J. T., Delcampe A., Brockow K., Seminario-Vidal L., Jörg L., Watson M. P., Gonçalo M., Lucas M., Torres M., Noe M. H., Hama N., Shear N. H., O’Reilly P., Wolkenstein P., Romanelli P., Dodiuk-Gad R. P., Micheletti R. G., Tiplica G. S., Sheridan R., Rauz S., Ahmad S., Chua S. L., Flynn T. H., Pichler W., Le S. T., Maverakis E., Walsh S., French L. E., Brüggen M. C.
Abstract
Abstract
Background
Long-term sequelae are frequent and often disabling after epidermal necrolysis (Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)). However, consensus on the modalities of management of these sequelae is lacking.
Objectives
We conducted an international multicentric DELPHI exercise to establish a multidisciplinary expert consensus to standardize recommendations regarding management of SJS/TEN sequelae.
Methods
Participants were sent a survey via the online tool “Survey Monkey” consisting of 54 statements organized into 8 topics: general recommendations, professionals involved, skin, oral mucosa and teeth, eyes, genital area, mental health, and allergy workup. Participants evaluated the level of appropriateness of each statement on a scale of 1 (extremely inappropriate) to 9 (extremely appropriate). Results were analyzed according to the RAND/UCLA Appropriateness Method.
Results
Fifty-two healthcare professionals participated. After the first round, a consensus was obtained for 100% of 54 initially proposed statements (disagreement index < 1). Among them, 50 statements were agreed upon as ‘appropriate’; four statements were considered ‘uncertain’, and ultimately finally discarded.
Conclusions
Our DELPHI-based expert consensus should help guide physicians in conducting a prolonged multidisciplinary follow-up of sequelae in SJS-TEN.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Reference56 articles.
1. Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Severe cutaneous adverse reactions to drugs. Lancet. 2017;390:1996–2011. 2. Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008;128:35–44. 3. Monnet P, Rodriguez C, Gaudin O, Cirotteau P, Papouin B, Dereure O, et al. Towards a better understanding of adult idiopathic epidermal necrolysis: a retrospective study of 19 cases. J Eur Acad Dermatol Venereol. 2021;35:1569–76. 4. Kuijper EC, French LE, Tensen CP, Vermeer MH, Bouwes Bavinck JN. Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN). J Eur Acad Dermatol Venereol. 2020;34(9):1957–71. 5. Lalevée S, Contassot E, Ortonne N, Gaudin O, Ben Said B, Vocanson M, et al. Advances in understanding of the pathophysiology of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis). Ann Dermatol Venereol. 2020;147:475–81.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|